BFBiyoloji Bolumu Istanbul Universitesi Fen Fakultesi
Biyoloji Bolumu Istanbul Universitesi Fen Fakultesi
+4
Objective: The purpose of this investigation was to compare the effect of alprazolam and melatonin on oxidative stress, glicocalyx integrity and neurocognitive function in patients undergoing coronary artery bypass grafting (CABG). Methods: Overall, 42 patients undergoing CABG were retrospectively included in this study. Blood samples which preserved at -70 degrees C for a previous study were used for this study. The participants were divided into two groups. Patients in the Group A were administered alprazolam before the operation, whereas melatonin was used for premedication in the Group M. Blood samples were collected at three time points [T0: before anaesthesia induction, T1: admittance to intensive care unit (ICU), T2: 24 h after ICU admission], and oxidative stress parameters and glicocalyx integrity were evaluated. Furthermore, Mini-Mental State Examination was recorded to measure neurocognitive function. Results: The total thiol levels which were measured as an antioxidant parameter were significantly higher, and free Hb values were significantly lower in the Group M compared to the Group A (p0.05). Conclusion: In light of positive effects on oxidatif stress parameters, melatonin may be considered as a good and safe premedication agent with its anxiolytic, antioxidant and minimal haemodynamic and respiratory effects.
BACKGROUND Benzodiazepines are the most popular premedication drugs thought to act through the GABA/benzodiazepine receptor complex and alprazolam is one of the most potent benzodiazepines that have a quick onset. While there is a growing body of evidence supporting alprazolam in the amelioration of redox status in animals, no study has been performed concerning its antioxidant activity in humans. The purpose of this investigation was to determine the effect of alprazolam on redox status. MATERIAL AND METHODS This study was a four-group randomized controlled trial. Participants were recruited from Acibadem University Acibadem International Hospital and included a convenience sample of 82 donors and recipients undergoing renal transplantation. Patients were randomly divided into four groups. While donors and recipients in experimental groups (G1 and G3) were administered alprazolam 0.5 mg orally one hour before the operation, those in control groups (G2 and G4) were not. Serum advanced oxidative protein products, total thiol, free hemoglobin, ischemic modified albumin, and sialic acid levels at different time points were measured to evaluate the redox status. RESULTS All oxidative stress parameters were higher in the alprazolam premedication groups (G1, G3) at all time points than in the control groups (G2, G4). Basal values of oxidative parameters (at time point T1) in patients with CKD (G3, G4) were lower than in healthy donors (G1, G2). CONCLUSIONS Alprazolam premedication in donors and end-stage renal failure patients undergoing renal transplantation does not improve redox homeostasis but further experimental studies are needed.
Amaç: Bu çalışmanın amacı nöromusküler monitörizasyon ve anestezi derinliği monitorizasyonu yapılan hastalarda sigara içimi ile nondepolarizan bir nöromusküler bloker olan rokuronyum bromidin etki süresindeki değişimin araştırılmasıdır. Materyal ve metod: Çalışmaya, her grupta 29 olmak üzere toplam 58 hasta dahil edildi. Hastalar, hiç sigara kullanmayan hastalar (n=29) ve bir günde en az 10 adet sigarayı en az 2 yıl süreyle devamlı kullanan hastalar (n=29) olmak üzere iki gruba ayrıldı. Tüm hastalarda hedef kontrollü infüzyon yöntemi ile total intravenöz anestezi yöntemi uygulandı. Hastaların intraoperatif hemodinamik parametreleri ve BİS değerleri takip edildi. Doz ihtiyaci, “lag time”, “onset time”, “derin nöromusküler blok süresi”, “T1 %10 süresi”, “klinik etki süresi”, “derlenme indeksi”, “komplet derlenme aralığı” değerleri her hasta için kaydedildi. Bulgular: Çalışmamızda lag-time değerlerinde sigara içmeyenler ve sigara içenler arasında anlamlı fark gözlenmedi (60±17 saniye ve 60±11saniye, p>0.05). Onset-time değerleri sigara içmeyen ve içenlerde 105±34 saniye ve 120±46 saniye iken , derin nöromusküler blok zamanı yine sigara içmeyen ve içenlerde 28±13.7 dakika ve 33.7±9.3 dakika idi. T1 10% suresi ve klinik etki suresi değerleri de sigara içmeyen ve sigara içenlerde 15.5±7.6/17.2±5.8 dakika ve 16.5±11.1/18.25±7.3 dakika idi (p>0.05). Benzer şekilde derlenme indeksi de sigara içmeyenler (12.7±7.3) ve içenler (12.4±6.6) arasinda anlamlı fark göstermedi. Sonuç: Çalışmamızda "lag-time", "onset-time", "derin nöromusküler blok süresi", "klinik etki süresi", "T1 %10 süresi", "derlenme indeksi", "komplet derlenme aralığı" değerleri karşılaştırıldığında gruplar arasında istatistiksel olarak anlamlı bir fark saptanmadı.